|
EIKN Eikon Therapeutics Inc 1861123 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-82,958,000.00 |
| Balance Sheet |
|
Current Assets
|
$529,501,000.00 |
|
Assets
|
$850,826,000.00 |
|
Current Liabilities
|
$45,064,000.00 |
|
Liabilities
|
$300,155,000.00 |
|
Equity
|
$550,671,000.00 |
|
Shares Out
|
54138555.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-89,801,000.00 |
|
Investing Cash Flow
|
$-203,217,000.00 |
| Market Analysis |
Market Cap
|
$520,812,899.10 |
|
Price
|
$9.34 |
|
BVPS
|
10.17 |
|
PB
|
0.95 |
|
EPS
|
-2.46 |
|
PE
|
0.63 |
|
FCF
|
$-90,063,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:25 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EIKN documents filed with the SEC.
EIKN Filings
Clear
